SCHEMBL7140111

SCHEMBL7140111

COC=C(C(=O)OC)c1ccccc1C=CC=Cc1cccc(OC)c1[N+](=O)[O-]

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 2/20 0.46
HPGD P15428 2/20 0.44
MAPT P10636 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
NFE2L2 Q16236 2/20 0.40
NR1H4 Q96RI1 1/20 0.40
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MAOB P27338 1/20 0.39
TFEB P19484 1/20 0.39
ALDH1A1 P00352 2/20 0.39
GAA P10253 1/20 0.39
GFER P55789 1/20 0.39
LMNA P02545 1/20 0.39
MEN1 O00255 1/20 0.39
POLB P06746 1/20 0.39
KMT2A Q03164 1/20 0.39
KDM4E B2RXH2 1/20 0.39
TRPA1 O75762 1/20 0.38
TRPM8 Q7Z2W7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7140107 1.00 AR (0.46) ARHPGDMAPTNPSR1NFE2L2
SCHEMBL7137704 0.91 AR (0.46) ARHPGDMAPTNFE2L2NR1H4
SCHEMBL7137706 0.91 AR (0.46) ARHPGDMAPTNFE2L2NR1H4
SCHEMBL7136375 0.77 KDM1A (0.46) ARHPGDMAPTNFE2L2MAOB
SCHEMBL7135372 0.77 KDM1A (0.46) ARHPGDMAPTNFE2L2MAOB
SCHEMBL12852970 0.76 CTSD (0.51) HPGDMAPTRAB9ASMN1; SMN2GAA
SCHEMBL7135428 0.76 LY96 (0.47) ARNFE2L2MAOBMEN1POLB
SCHEMBL7136740 0.76 HCAR2 (0.41) ARNFE2L2MAOBTFEBPOLB
SCHEMBL7136721 0.76 HCAR2 (0.41) ARNFE2L2MAOBTFEBPOLB
SCHEMBL8149420 0.75 LMNA (0.42) ARMAPTNPSR1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0996439-B1 BETA-ALKOXYACRYLATES AGAINST MALARIA HOFFMANN LA ROCHE (CH) 2003-01-08 EP claimed
US-6084120-A ACTIVE AGAINST CHLOROQUINE-SENSITIVE PATIENTS AND AGAINST CHLOROQUINE-RESISTANT MALARIA PATHOGENS; PROPHYLAXIS AND TREATMENT; E.G., A 3 METHOXY-2-(2-(4-PHENYLBUTA-1,3-DIEN-1-YL)PHENYL)ACRYLIC ACID HOFFMANN-LA ROCHE INC. (US) 2000-07-04 US claimed
US-6084120-A ACTIVE AGAINST CHLOROQUINE-SENSITIVE PATIENTS AND AGAINST CHLOROQUINE-RESISTANT MALARIA PATHOGENS; PROPHYLAXIS AND TREATMENT; E.G., A 3 METHOXY-2-(2-(4-PHENYLBUTA-1,3-DIEN-1-YL)PHENYL)ACRYLIC ACID HOFFMANN-LA ROCHE INC. (US) 2000-07-04 US disclosed